DICOT PHARMA AB

Insiders Dicot Pharma AB

Equities

DICOT

SE0011178458

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
0.379 ^SEK	-18.32%		-6.88%	+19.18%

06-06	Dicot Pharma AB Develops LIB-01 into A New Potency Drug with Improved Properties Compared to Currently Available Drugs	CI
05-06	Dicot Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dicot AB Appoints Mats Silvander as New chief technical officer	03/05/23	CI
Dicot AB Announces Lena Söderström Not Stands for Re-Election as a Director	04/04/23	CI
Dicot Names New Chief Scientific Officer	19/04/22	MT
Dicot AB Appoints Charlotta Gauffin as Chief Scientific Officer	19/04/22	CI
Dicot AB Announces Board Changes	07/04/22	CI
Dicot AB Announces CEO Changes	01/04/22	CI
Dicot Announces CEO Changes, Effective April 1, 2022	07/02/22	CI
Dicot AB Announces Election of Eva Sjökvist Saers as the Chairman of Board, At the Extraordinary General Meeting Held on February 9, 2021	09/02/21	CI
Dicot AB Announces Executive Changes	11/12/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer